NAT10 drives ovarian cancer progression via NLRP3 mRNA ac4C modification
Discover Oncology · 09.05.2026 · 17 (1)
DOI: 10.1007/s12672-026-04728-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 09.05.2026. Verfasst von Yu Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Department, Changning Maternity and Infant Health Hospital, East China Normal University, No. 786, Yuyuan Road, Changning District, Shangh…. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecology Department, Changning Maternity and Infant Health Hospital, East China Normal University, No. 786, Yuyuan Road, Changning District, Shanghai, 200051, China.
- Department of Radiology, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai, 200434, China.
- Gynecology Department, Changning Maternity and Infant Health Hospital, East China Normal University, No. 786, Yuyuan Road, Changning District, Shanghai, 200051, China. cbma1966@sina.com.
- Department of Gynecology and Obstetrics, International Peace Maternity and Child Health Hospital, Shanghai Jiaotong University, Shanghai, 200030, China. lping1016@163.com.
Zitieren
APA
Liu, Y., Yang, Y., Wang, C. C., Zhang, W. Y., Cao, L., Ma, C. B., & Liu, P. (2026). NAT10 drives ovarian cancer progression via NLRP3 mRNA ac4C modification. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-04728-4
Vancouver
Liu Y, Yang Y, Wang CC, Zhang WY, Cao L, Ma CB, et al. NAT10 drives ovarian cancer progression via NLRP3 mRNA ac4C modification. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-04728-4
BibTeX
@article{Liu2026,
author = {Liu, Yu and Yang, Yu and Wang, Chun-Chun and Zhang, Wen-Ying and Cao, Lei and Ma, Cheng-Bin and Liu, Ping},
title = {NAT10 drives ovarian cancer progression via NLRP3 mRNA ac4C modification},
journal = {Discover Oncology},
year = {2026},
volume = {17},
number = {1},
doi = {10.1007/s12672-026-04728-4}
}
EUVIMED